Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation

doi:10.3748/wjg.v23.i7.1171

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8994)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

471

WORD

285

HTML

4832

Figures (1-6)

620

Sum=6208

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1092

Download

1694

Sum=2786

Feb 21, 2017 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (56)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Feb 21, 2017; 23(7): 1171-1179
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1171

Full Size Figure Download Figure

Figure 6 Impact of thymoquinone and/or prostaglandin E2 administration on tumor growth in nude mice xenografts. Tumor tissues were harvested from nude mice and lysed. Protein content was quantified and analyzed by immunoblotting. p-Akt, β-catenin and COX-2 levels in LoVo cells were detected. PGE2: Prostaglandin E2; TQ: Thymoquinone.

Citation: Hsu HH, Chen MC, Day CH, Lin YM, Li SY, Tu CC, Padma VV, Shih HN, Kuo WW, Huang CY. Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation. World J Gastroenterol 2017; 23(7): 1171-1179
URL: https://www.wjgnet.com/1007-9327/full/v23/i7/1171.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i7.1171